STAAR Surgical to Participate in Upcoming Investor Conferences
September 02 2020 - 7:00AM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of implantable lenses and companion
delivery systems for the eye, today announced that management will
participate in several upcoming investor conferences. The Company
has issued an updated investor presentation it will use during the
upcoming meetings, which is available on the Company’s investor
website at investors.staar.com.
Caren Mason, President & CEO, and Patrick F. Williams, CFO,
will participate in the following investor conferences during the
month of September:
- William Blair West Coast Field Trip 2020, Wednesday,
September 2
- Wells Fargo 2020 Virtual Healthcare Conference,
Wednesday, September 9
- Morgan Stanley 18th Annual Global Healthcare Conference,
Monday, September 14
- Sidoti & Co. Small Cap Virtual Investor Conference,
Thursday, September 24
Attendance at the investor conferences is by invitation only
from each sponsoring research brokerage firm. Please contact the
brokerage firm directly for more information.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 30 years, designs, develops, manufactures and markets
implantable lenses for the eye with companion delivery systems.
These lenses are intended to provide visual freedom for patients,
lessening or eliminating the reliance on glasses or contact lenses.
All of these lenses are foldable, which permits the surgeon to
insert them through a small incision. STAAR’s lens used in
refractive surgery is called an Implantable Collamer® Lens or
“ICL”, which includes the EVO Visian ICL™ product line. More than
1,000,000 Visian® ICLs have been implanted to date and STAAR
markets these lenses in over 75 countries. To learn more about the
ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA,
the company operates manufacturing and packaging facilities in
Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more
information, please visit the Company’s website at
www.staar.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200902005311/en/
Investors & Media Brian Moore Vice President,
Investor, Media Relations and Corporate Development (626) 303-7902,
Ext. 3023 bmoore@staar.com
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Mar 2024 to Apr 2024
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Apr 2023 to Apr 2024